These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 32526626)

  • 1. Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'.
    Roy AS; Matson M; Herlekar R
    Diabetes Metab Syndr; 2020; 14(5):777. PubMed ID: 32526626
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Multimorbidity and SARS-CoV-2 infection in UK biobank'.
    Sur Roy A; Joshi A
    Diabetes Metab Syndr; 2020; 14(5):969. PubMed ID: 32604017
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.).
    Grant WB; McDonnell SL
    Diabetes Metab Syndr; 2020; 14(5):893-894. PubMed ID: 32563941
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.).
    Chudasama YV; Zaccardi F; Khunti K
    Diabetes Metab Syndr; 2020; 14(5):1281. PubMed ID: 32755821
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.
    Kasparian K; Graykowski D; Cudaback E
    Front Immunol; 2020; 11():1939. PubMed ID: 33042114
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.
    Nikogosov DA; Shevlyakov AD; Baranova AV
    J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2233-2234. PubMed ID: 32803253
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and risk of COVID-19: analysis of UK biobank.
    Yates T; Razieh C; Zaccardi F; Davies MJ; Khunti K
    Prim Care Diabetes; 2020 Oct; 14(5):566-567. PubMed ID: 32493608
    [No Abstract]   [Full Text] [Related]  

  • 8. ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank.
    Kuo CL; Pilling LC; Atkins JL; Masoli JAH; Delgado J; Kuchel GA; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1801-1803. PubMed ID: 32623451
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.
    Kuo CL; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2235-2236. PubMed ID: 32797154
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 severity in African Americans - A role for Duffy Null?
    Hebbel RP; Vercellotti GM
    Haematologica; 2020 Dec; 105(12):2892. PubMed ID: 33054139
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethnicity and COVID-19 infection: are the pieces of the puzzle falling into place?
    Mulholland RH; Sinha IP
    BMC Med; 2020 Jul; 18(1):206. PubMed ID: 32605617
    [No Abstract]   [Full Text] [Related]  

  • 12. Multimorbidity and SARS-CoV-2 infection in UK Biobank.
    Chudasama YV; Gillies CL; Appiah K; Zaccardi F; Razieh C; Davies MJ; Yates T; Khunti K
    Diabetes Metab Syndr; 2020; 14(5):775-776. PubMed ID: 32526625
    [No Abstract]   [Full Text] [Related]  

  • 13. Biobanking During the COVID-19 Pandemic.
    Vaught J
    Biopreserv Biobank; 2020 Jun; 18(3):153-154. PubMed ID: 32297797
    [No Abstract]   [Full Text] [Related]  

  • 14. Pandemics: global biobanking for equitable testing.
    Basile AJ; Hampton LM
    Nature; 2020 Nov; 587(7833):197. PubMed ID: 33173224
    [No Abstract]   [Full Text] [Related]  

  • 15. Sampling the host response to SARS-CoV-2 in hospitals under siege.
    Charney AW; Simons NW; Mouskas K; Lepow L; Cheng E; Le Berichel J; Chang C; Marvin R; Del Valle DM; Calorossi S; Lansky A; Walker L; Patel M; Xie H; Yi N; Yu A; Kang G; Mendoza A; Liharska LE; Moya E; Hartnett M; Hatem S; Wilkins L; Eaton M; Jamal H; Tuballes K; Chen ST; Tabachnikova A; Chung J; Harris J; Batchelor C; Lacunza J; Yishak M; Argueta K; Karekar N; Lee B; Kelly G; Geanon D; Handler D; Leech J; Stefanos H; Dawson T; Scott I; Francoeur N; Johnson JS; Vaid A; Glicksberg BS; Nadkarni GN; Schadt EE; Gelb BD; Rahman A; Sebra R; Martin G; ; Marron T; Beckmann N; Kim-Schulze S; Gnjatic S; Merad M
    Nat Med; 2020 Aug; 26(8):1157-1158. PubMed ID: 32719485
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin D and Covid-19: A Note of Caution.
    Rabbitt L; Slattery E
    Ir Med J; 2020 May; 113(5):82. PubMed ID: 32603574
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Jakovac: COVID-19, vitamin D, and type I interferon.
    Gauzzi MC; Fantuzzi L
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E245-E246. PubMed ID: 32672049
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin D deficiency and the COVID-19 pandemic.
    Zemb P; Bergman P; Camargo CA; Cavalier E; Cormier C; Courbebaisse M; Hollis B; Joulia F; Minisola S; Pilz S; Pludowski P; Schmitt F; Zdrenghea M; Souberbielle JC
    J Glob Antimicrob Resist; 2020 Sep; 22():133-134. PubMed ID: 32474141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19, Cocooning and Vitamin D Intake Requirements.
    McKenna MJ; Flynn MAT
    Ir Med J; 2020 May; 113(5):79. PubMed ID: 32603573
    [No Abstract]   [Full Text] [Related]  

  • 20. Unlocking UK COVID-19 policy.
    Colbourn T
    Lancet Public Health; 2020 Jul; 5(7):e362-e363. PubMed ID: 32502388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.